Trial Profile

An Open-label Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Rosuvastatin Extended Release Capsules in Healthy Volunteers

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 02 Dec 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Rosuvastatin (Primary) ; Rosuvastatin (Primary)
Indications Dyslipidaemias
Focus Adverse reactions; Pharmacokinetics
Sponsors Lyndra

Most Recent Events

01 Dec 2021 Status changed from recruiting to completed.
28 Jan 2021 New trial record
21 Jan 2021 According to a Lyndra Therapeutics media release, the first subject has been dosed in this study.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com